- Published on
Infectious Disease and Microbiology – Thrombophlebitis
Suppurative, or septic, thrombophlebitis is an infectious inflammation of a vein accompanied by thrombus formation and bacteremia. It may involve superficial veins, central veins including pelvic veins, intracranial venous structures, or the portal venous system.
Septic thrombophlebitis occasionally complicates central venous catheter-associated bloodstream infection, including infections related to peripherally inserted central catheters (PICC lines).
Epidemiology
Superficial suppurative thrombophlebitis is an important healthcare-associated infection and is usually related to skin and soft-tissue infection or an indwelling intravenous catheter.
Risk increases when peripheral intravenous catheters remain in place for prolonged periods, particularly for three days or longer.
Lower-extremity intravenous catheters are associated with a greater risk than upper-extremity cannulation.
Patients with extensive burns are particularly vulnerable, followed by those with malignancy or receiving systemic corticosteroids.
Septic pelvic thrombophlebitis is uncommon but is primarily associated with pregnancy, cesarean delivery, gynecologic surgery, or septic abortion.
Pelvic septic thrombophlebitis generally develops approximately one to two weeks after delivery or pelvic surgery.
Risk factors
Important risk factors for septic pelvic thrombophlebitis include cesarean delivery, pregnancy, pelvic infection, induced abortion, pelvic surgery, uterine fibroids, malignancy, and hormonal stimulation.
For catheter-associated disease, prolonged venous cannulation, burns, immunosuppression, malignancy, and contamination of the catheter or infusion system increase the likelihood of infection.
Prevention
Avoiding unnecessary venous catheterization and using meticulous sterile technique are fundamental preventive measures.
When possible, lower-extremity peripheral cannulation should be avoided, particularly in patients at increased risk of bloodstream infection.
Catheter insertion sites should be managed using appropriate skin antisepsis and aseptic technique, and unnecessary intravascular catheters should be removed promptly.
Antimicrobial-impregnated central venous catheters may be considered in selected patients or units with persistently high catheter-related infection rates despite strict adherence to standard infection-control practices.
Maximal sterile barrier precautions during central venous catheter insertion remain an important component of prevention.
Pathophysiology
Septic thrombophlebitis develops when a venous thrombus becomes infected, creating a protected nidus in which microorganisms can persist despite the host immune response.
Microorganisms may reach the vein by migration from the skin along a catheter tract, contamination of intravenous fluids or catheter equipment, or hematogenous spread from another infected focus.
The infected thrombus can continuously release organisms into the bloodstream, resulting in persistent or recurrent bacteremia.
Septic pelvic thrombophlebitis
Pelvic thrombophlebitis commonly affects the ovarian veins or inferior vena cava.
Pregnancy and the postpartum state promote venous thrombosis through venous stasis and physiologic hypercoagulability.
Bacteria from vaginal or perineal flora may subsequently infect the thrombus.
Common organisms include Bacteroides species, streptococci, and Enterobacteriaceae such as Escherichia coli.
Portal vein septic thrombophlebitis
Infection and thrombosis of the portal venous system, sometimes called pylephlebitis, may develop secondary to intra-abdominal infection.
It can be associated with hepatic abscesses, although an obvious extrahepatic source is not always found.
Intracranial suppurative thrombophlebitis
Intracranial septic thrombophlebitis may involve cerebral veins or the major dural venous sinuses.
It may occur after infections involving the paranasal sinuses, middle ear, mastoid, facial skin, or oropharynx.
It can also complicate epidural abscess, subdural empyema, bacterial meningitis, or hematogenous dissemination from a distant infectious focus.
Cavernous sinus thrombosis
Septic cavernous sinus thrombosis most commonly develops after paranasal sinusitis or infections involving the face, nose, teeth, or oral cavity.
Staphylococcus aureus is the most important pathogen and is responsible for the majority of septic cavernous sinus thrombosis cases.
Other possible organisms include streptococci, pneumococci, gram-negative bacilli, and anaerobes such as Bacteroides.
In immunocompromised patients or in the appropriate clinical setting, invasive fungi including Aspergillus, Mucor, and Rhizopus should also be considered.
Etiology of superficial disease
The most commonly isolated pathogen in superficial suppurative thrombophlebitis is Staphylococcus aureus.
Other organisms include coagulase-negative staphylococci, Enterobacteriaceae, Pseudomonas aeruginosa, enterococci, and Candida species.
Anaerobic organisms are considerably less common in superficial catheter-associated infections.
Clinical presentation
Fever occurs in most patients with septic thrombophlebitis, although shaking chills or rigors may be absent.
Patients with infection of the large central thoracic veins often present primarily with bacteremia or sepsis and may have few or no local findings.
Persistent bloodstream infection despite appropriate antimicrobial therapy should raise suspicion for an infected intravascular thrombus.
Superficial thrombophlebitis
Superficial septic thrombophlebitis usually produces recognizable local findings.
The affected vein may demonstrate erythema, warmth, tenderness, induration, and lymphangitic spread.
Local findings may be difficult to appreciate in patients with extensive burns or severely abnormal skin.
Pelvic septic thrombophlebitis
Patients commonly present with persistent high fever, chills, anorexia, nausea, vomiting, and lower abdominal or flank discomfort.
Pelvic thrombophlebitis should be considered when postpartum or postoperative fever persists despite apparently appropriate treatment for pelvic infection.
Intracranial thrombophlebitis
Clinical manifestations vary according to the affected venous structure and extent of intracranial involvement.
Patients may develop headache, seizures, focal neurologic deficits, altered consciousness, or manifestations of increased intracranial pressure.
Cavernous sinus thrombosis
Typical symptoms include fever, severe headache, and swelling around the eye.
Patients may also develop diplopia, photophobia, tearing, drowsiness, or changes in mental status.
Physical findings can include periorbital edema, chemosis, proptosis, ptosis, papilledema, and weakness of the extraocular muscles.
An early and particularly important neurologic sign is lateral gaze palsy, reflecting involvement of the abducens nerve.
Diagnosis
Diagnosis requires recognition of the combination of infection, venous thrombosis, and persistent bacteremia or local suppuration.
Blood cultures should be obtained before antimicrobial therapy whenever possible.
Superficial suppurative thrombophlebitis is frequently accompanied by bacteremia, making multiple blood cultures essential.
Routine laboratory studies may include a complete blood count, C-reactive protein, and erythrocyte sedimentation rate.
Persistent leukocytosis or inflammatory marker elevation can support the diagnosis but is nonspecific.
Imaging
Contrast-enhanced CT is particularly useful for detecting septic thrombosis of major central veins, pelvic veins, and the portal venous system.
CT can demonstrate venous filling defects, surrounding inflammatory changes, abscess formation, and extension of infection.
MRI, often combined with MR venography, is preferred when intracranial septic thrombophlebitis is suspected.
Venography can occasionally provide additional evidence of thrombosis in large thoracic central veins.
Catheter-associated infection
When an indwelling venous catheter is suspected as the source, the catheter should generally be removed promptly.
The catheter tip may be sent for microbiologic culture when clinically appropriate.
Persistent bacteremia after catheter removal increases concern for septic thrombosis, endocarditis, or another metastatic focus of infection.
Treatment of superficial septic thrombophlebitis
Prompt antimicrobial treatment is required because untreated disease may progress to sepsis, metastatic infection, or death.
Empiric therapy should cover S. aureus, including MRSA when appropriate.
Vancomycin is commonly used empirically when MRSA is a concern.
In burn patients, immunocompromised individuals, or patients at high risk for gram-negative infection, additional coverage against gram-negative bacilli including Pseudomonas aeruginosa may be necessary.
Antimicrobial treatment should subsequently be narrowed according to blood, catheter, or tissue culture results.
Surgical treatment
Most superficial infections respond to catheter removal and appropriate antimicrobial therapy.
Excision of the infected vein may be required if persistent bacteremia, suppuration, or sepsis continues despite adequate antibiotic therapy and source control.
Treatment of septic pelvic thrombophlebitis
Treatment requires broad-spectrum intravenous antibiotics directed against gram-negative organisms, streptococci, and anaerobes.
Appropriate regimens may include a broad-spectrum β-lactam/β-lactamase inhibitor, a carbapenem, or a cephalosporin combined with anaerobic coverage, depending on local resistance patterns and patient factors.
Anticoagulation with heparin has historically been used in some patients, but its role is not universal and should be individualized according to the clinical situation.
Treatment of intracranial septic thrombophlebitis
Intracranial disease requires urgent high-dose intravenous antimicrobial therapy covering staphylococci, streptococci, gram-negative organisms when appropriate, and anaerobes according to the suspected source.
Vancomycin should be included when MRSA is possible.
Treatment should also aggressively address the primary infectious focus, such as sinusitis, mastoiditis, dental infection, or intracranial abscess.
The role of anticoagulation in septic intracranial thrombophlebitis remains controversial and generally requires individualized assessment involving infectious disease, neurology, neurosurgery, and hematology expertise.
Follow-up
Patients with suppurative thrombophlebitis require close follow-up because relapse can occur if infected thrombus remains.
Repeat blood cultures are important to document clearance of bacteremia.
In selected severe cases, surveillance cultures after completion of therapy may be considered when recurrent bloodstream infection is a major concern.
Patients with unexplained bacteremia, particularly those with burns or recent intravenous catheterization, should have previous catheter sites and cannulated veins carefully examined.
Complications
The infected thrombus may serve as a source of continuous or intermittent bacteremia, leading to sepsis and septic shock.
Metastatic infection may produce pneumonia, septic pulmonary emboli, distant abscesses, or acute bacterial endocarditis.
Intracranial disease can produce cerebral infarction, seizures, meningitis, brain abscess, cranial nerve deficits, or increased intracranial pressure.
High-Yield Pattern
Peripheral IV site + erythema/tenderness + bacteremia → suspect superficial septic thrombophlebitis
Persistent bacteremia after catheter removal → consider septic central venous thrombosis
Postpartum fever despite antibiotics + pelvic or flank pain → consider septic pelvic thrombophlebitis
Sinus/facial infection + fever + proptosis/ophthalmoplegia → suspect septic cavernous sinus thrombosis
Diagnosis → blood cultures + contrast vascular imaging
Treatment → remove infected catheter/source + prolonged targeted IV antibiotics ± drainage or vein excision
Persistent infection despite therapy → search for endocarditis, abscess, or residual infected thrombus